The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.
about
The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The JAK2 inhibitors CEP-33779 ...... t cancer cells to vincristine.
@en
The JAK2 inhibitors CEP-33779 ...... t cancer cells to vincristine.
@nl
type
label
The JAK2 inhibitors CEP-33779 ...... t cancer cells to vincristine.
@en
The JAK2 inhibitors CEP-33779 ...... t cancer cells to vincristine.
@nl
prefLabel
The JAK2 inhibitors CEP-33779 ...... t cancer cells to vincristine.
@en
The JAK2 inhibitors CEP-33779 ...... t cancer cells to vincristine.
@nl
P2093
P1476
The JAK2 inhibitors CEP-33779 ...... nt cancer cells to vincristine
@en
P2093
Hyung Sik Kim
Ji Hyun Cheon
Kyeong Seok Kim
Mihyun Kim
Sungpil Yoon
P304
P356
10.1016/J.BBRC.2017.06.178
P407
P577
2017-06-29T00:00:00Z